Literature DB >> 12401328

Nicotinic receptors mediate increased GABA release in brain through a tetrodotoxin-insensitive mechanism during prolonged exposure to nicotine.

P J Zhu1, V A Chiappinelli.   

Abstract

The effects of nicotine on the spontaneous release of GABA from nerve terminals in the chick lateral spiriform nucleus were examined using whole cell patch-clamp recording in brain slices. Exposure to 1 microM nicotine produced an early immediate increase in the frequency of spontaneous postsynaptic GABAergic currents. This effect was blocked in the presence of 0.5 microM tetrodotoxin. However, a prolonged application of 0.1-1 microM nicotine (>3 min) caused a tetrodotoxin-insensitive increase in the frequency of spontaneous GABAergic currents. This late tetrodotoxin-insensitive effect was blocked by the nicotinic antagonists dihydro-beta-erythroidine (30 microM) and mecamylamine (10 microM), but not by methyllycaconitine (50-100 nM), indicating that activation of high affinity nicotine receptors was mainly responsible for this effect. This enhancement was inhibited by the high threshold Ca(2+) channel blocker Cd(2+) (100 microM), but not by dantrolene or ryanodine. The tetrodotoxin-insensitive enhancement of the frequency of GABA currents by nicotine was reduced by inhibition of cAMP-dependent protein kinase with HA1004 (30 microM), but not by inhibition of protein kinase C with staurosporine (1 microM), and was facilitated by forskolin (10 microM) or bromo-cAMP (50 microM). The results indicate that nicotine-enhanced GABA release can operate through both tetrodotoxin-sensitive and -insensitive mechanisms in a single brain region and that a second messenger cascade may be involved in the tetrodotoxin-insensitive enhancement by nicotine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401328     DOI: 10.1016/s0306-4522(02)00371-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.

Authors:  Janice W Smith; Adrian Mogg; Elisiana Tafi; Eleanor Peacey; Ian A Pullar; Philip Szekeres; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2006-11-18       Impact factor: 4.530

2.  Single dose varenicline may trigger epileptic activity.

Authors:  Haydar Ali Erken; Gülten Erken; Hasan Simşek; Oğuzhan Korkut; Emine Rabia Koç; Ozlem Yavuz; Osman Genç
Journal:  Neurol Sci       Date:  2014-06-07       Impact factor: 3.307

3.  The effect of epibatidine on spontaneous and evoked neurotransmitter release in the mouse and guinea pig isolated vas deferens.

Authors:  D J Williams; K L Brain; T C Cunnane
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

Review 4.  Prenatal nicotine exposure and development of nicotinic and fast amino acid-mediated neurotransmission in the control of breathing.

Authors:  Ralph F Fregosi; Jason Q Pilarski
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

5.  Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.

Authors:  Krista Spiller; Zheng-Xiong Xi; Xia Li; Charles R Ashby; Patrick M Callahan; Ashok Tehim; Eliot L Gardner
Journal:  Neuropharmacology       Date:  2009-04-22       Impact factor: 5.250

6.  Nicotinic receptor-mediated biphasic effect on neuronal excitability in chick lateral spiriform neurons.

Authors:  Y-B Liu; J-Z Guo; V A Chiappinelli
Journal:  Neuroscience       Date:  2007-07-17       Impact factor: 3.590

7.  Smoking, Genetics and Schizophrenia: Evidence for Self Medication.

Authors:  Sherry Leonard; Sharon Mexal; Robert Freedman
Journal:  J Dual Diagn       Date:  2007-11-01

8.  Gamma-aminobutyric acid mediates nicotine biosynthesis in tobacco under flooding stress.

Authors:  Xiaoming Zhang; Hua-Ming Lin; Hong Hu; Xiangyang Hu; Liwei Hu
Journal:  Plant Divers       Date:  2016-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.